Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

SELL
$0.8 - $1.12 $464,025 - $649,635
-580,032 Reduced 78.89%
155,222 $173,000
Q3 2022

Nov 14, 2022

SELL
$0.91 - $1.69 $815,664 - $1.51 Million
-896,335 Reduced 54.94%
735,254 $575,000
Q2 2022

Aug 12, 2022

SELL
$1.28 - $2.4 $74,648 - $139,965
-58,319 Reduced 3.45%
1,631,589 $2.77 Million
Q1 2022

May 13, 2022

SELL
$2.19 - $6.09 $16,065 - $44,676
-7,336 Reduced 0.43%
1,689,908 $3.7 Million
Q4 2021

Feb 14, 2022

BUY
$5.81 - $14.39 $140,869 - $348,899
24,246 Added 1.45%
1,697,244 $10.4 Million
Q3 2021

Nov 12, 2021

BUY
$11.55 - $20.3 $19.3 Million - $34 Million
1,672,998 New
1,672,998 $23.2 Million

Others Institutions Holding GTH

# of Institutions
1
Shares Held
7.5K
Call Options Held
0
Put Options Held
0

About Genetron Holdings Ltd


  • Ticker GTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 90,602,304
  • Description
  • Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagn...
More about GTH
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.